Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'COAGULATION FACTOR-V' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 530 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Pastacaldi, S; Teixeira, R; Montalto, P; Rolles, K; Burroughs, AK
      Hepatic artery thrombosis after orthotopic liver transplantation: A reviewof nonsurgical causes

      LIVER TRANSPLANTATION
    2. Grimm, DR; Colter, MB; Braunschweig, M; Alexander, LJ; Neame, PJ; Kim, HKW
      Porcine factor V: cDNA cloning, gene mapping, three-dimensional protein modeling of membrane binding sites and comparative anatomy of domains

      CELLULAR AND MOLECULAR LIFE SCIENCES
    3. Gold, B; Hanson, M; Dean, M
      Two rare confounding polymorphisms proximal to the factor V Leiden mutation

      MOLECULAR DIAGNOSIS
    4. Rhodes, RB; Lewis, K; Shultz, J; Huber, S; Voelkerding, KV; Leonard, DGB; Tsongalis, GJ; Kephart, DD
      Analysis of the factor V Leiden mutation using the READIT Assay

      MOLECULAR DIAGNOSIS
    5. Kamphuisen, PW; Eikenboom, JCJ; Bertina, RM
      Elevated factor VIII levels and the risk of thrombosis

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    6. Sampram, ESK; Lindblad, B
      The impact of Factor V mutation on the risk for occlusion in patients undergoing peripheral vascular reconstructions

      EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY
    7. Lopaciuk, S; Bykowska, K; Kwiecinski, H; Mickielewicz, A; Czlonkowska, A; Mendel, T; Kuczynska-Zardzewialy, A; Szelagowska, D; Windyga, J; Schroder, W; Herrmann, FH; Jedrzejowska, H
      Factor V Leiden, prothrombin gene G20210A variant, and methylenetetrahydrofolate reductase C677T genotype in young adults with ischemic stroke

      CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
    8. Mira, Y; Todoli, J; Alonso, R; Mico, ML; Vaya, A; Ferrando, F; Estelles, A; Villa, P; Aznar, J
      Factor V Leiden and prothrombin G20210A in relation to arterial and/or vein rethrombosis: Two cases

      CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
    9. Wuthrich, RP
      Factor V Leiden mutation: potential thrombogenic role in renal vein, dialysis graft and transplant vascular thrombosis

      CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
    10. Linfert, DR; Tsongalis, GJ
      Coexistence of the methylenetetrahydrofolate reductase single-nucleotide polymorphism (C677T) in patients with the factor V Leiden or prothrombin G20210A polymorphisms

      DIAGNOSTIC MOLECULAR PATHOLOGY
    11. Quincampoix, JC; Legarff, M; Rittling, C; Andiva, S; Toulon, P
      Modification of the ProC (R) Global assay using dilution of patient plasmain factor V-depleted plasma as a screening assay for factor V Leiden mutation

      BLOOD COAGULATION & FIBRINOLYSIS
    12. Pecheniuk, NM; Morris, CP; Walsh, TP; Marsh, NA
      The factor V HR2 haplotype: prevalence and association of the A4070G and A6755G polymorphisms

      BLOOD COAGULATION & FIBRINOLYSIS
    13. Redondo, M; Carroll, VA; Mauron, T; Biasiutti, FD; Binder, BR; Lammle, B; Wuillemin, WA
      Hemostatic and fibrinolytic parameters in survivors of myocardial infarction: a low plasma level of plasmin-alpha 2-antiplasmin complex is an independent predictor of coronary re-events

      BLOOD COAGULATION & FIBRINOLYSIS
    14. Isermann, B; Hendrickson, SB; Hutley, K; Wing, M; Weiler, H
      Tissue-restricted expression of thrombomodulin in the placenta rescues thrombomodulin-deficient mice from early lethality and reveals a secondary developmental block

      DEVELOPMENT
    15. Irani-Hakime, N; Tamim, H; Elias, G; Choueiry, S; Kreidy, R; Daccache, JL; Almawi, WY
      Factor V R506Q mutation-Leiden: An independent risk factor for venous thrombosis but not coronary artery disease

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    16. Pinney, SP; Rabbani, LE
      Myocardial infarction in patients with normal coronary arteries: Proposed pathogenesis and predisposing risk factors

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    17. Verdu, A; Cazorla, MR; Granados, MA; Alonso, JA; Casado, LF
      Basilar artery thrombosis in a child heterozygous for factor V Leiden mutation

      PEDIATRIC NEUROLOGY
    18. Gopel, W; Gortner, L; Kohlmann, T; Schultz, C; Moller, J
      Low prevalence of large intraventricular haemorrhage in very low birthweight infants carrying the factor V Leiden or prothrombin G20210A mutation

      ACTA PAEDIATRICA
    19. Topaloglu, R; Akierli, C; Bakkaloglu, A; Aydintug, O; Ozen, S; Besbas, N; Ozcelik, T
      Survey of factor V Leiden and prothrombin gene mutations in systemic lupuserythematosus

      CLINICAL RHEUMATOLOGY
    20. Miles, JS; Miletich, JP; Goldhaber, SZ; Hennekens, CH; Ridker, PM
      G20210A mutation in the prothrombin gene and the risk of recurrent venous thromboembolism

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    21. Gurgey, A; Haznedaroglu, IC; Egesel, T; Buyukasik, Y; Ozcebe, OI; Sayinalp, N; Dundar, SV; Bayraktar, Y
      Two common genetic thrombotic risk factors: Factor V Leiden and prothrombin G20210A in adult Turkish patients with thrombosis

      AMERICAN JOURNAL OF HEMATOLOGY
    22. Weiss, HJ; Lages, B; Zheng, SL; Hayward, CPM
      Platelet factor V New York: A defect in factor V distinct from that in factor V Quebec resulting in impaired prothrombinase generation

      AMERICAN JOURNAL OF HEMATOLOGY
    23. Coen, D; Zadro, R; Honovic, L; Banfic, L; Rukavina, AS
      Prevalence and association of the factor V Leiden and prothrombin G20210A in healthy subjects and patients with venous thromboembolism

      CROATIAN MEDICAL JOURNAL
    24. Franco, RF; Reitsma, PH
      Genetic risk factors of venous thrombosis

      HUMAN GENETICS
    25. Merlini, PA; Ardissino, D
      Genetic polymorphisms to evaluate the risk of myocardial infarction: a long way away

      THROMBOSIS AND HAEMOSTASIS
    26. Saigo, M; Abe, S; Ogawa, M; Yamashita, T; Biro, S; Minagoe, S; Maruyama, I; Tei, C
      Imbalance of plasminogen activator inhibitor-I/tissue plasminogen activator and tissue factor/tissue factor pathway inhibitor in young Japanese men with myocardial infarction

      THROMBOSIS AND HAEMOSTASIS
    27. Butenas, S; Branda, RF; van't Veer, C; Cawthern, KM; Mann, KG
      Platelets and phospholipids in tissue factor-initiated thrombin generation

      THROMBOSIS AND HAEMOSTASIS
    28. Martinelli, I
      Risk factors in venous thromboembolism

      THROMBOSIS AND HAEMOSTASIS
    29. Heit, JA; Silverstein, MD; Mohr, DN; Petterson, TM; Lohse, CM; O'Fallon, WM; Melton, LJ
      The epidemiology of venous thromboembolism in the community

      THROMBOSIS AND HAEMOSTASIS
    30. Hoffman, M; Monroe, DM
      A cell-based model of hemostasis

      THROMBOSIS AND HAEMOSTASIS
    31. Izumi, T; Kim, SW; Greist, A; Macedo-Ribeiro, S; Fuentes-Prior, P; Bode, W; Kane, WH; Ortel, TL
      Fine mapping of inhibitory anti-factor V antibodies using factor V C2 domain mutants - Identification of two antigenic epitopes involved in phospholipid binding

      THROMBOSIS AND HAEMOSTASIS
    32. Bauer, KA
      Conventional fibrinolytic assays for the evaluation of patients with venous thrombosis: Don't bother

      THROMBOSIS AND HAEMOSTASIS
    33. Clark, P; Sattar, N; Walker, ID; Greer, IA
      The Glasgow outcome, APCR and lipid (GOAL) pregnancy study: Significance of pregnancy associated activated protein C resistance

      THROMBOSIS AND HAEMOSTASIS
    34. Hoekema, L; Castoldi, E; Tans, G; Girelli, D; Gemmati, D; Bernardi, F; Rosing, J
      Functional properties of factor V and factor Va encoded by the R2-gene

      THROMBOSIS AND HAEMOSTASIS
    35. Schwarz, T; Siegert, G; Mikulin, U; Gehrisch, S; Runge, E; Berg, LP; Koch, R; Schellong, SM
      Patients with persistent APC-resistance without factor V Leiden mutation

      VASA-JOURNAL OF VASCULAR DISEASES
    36. Linden, MD; Schneider, M; Erber, WN
      Factor V-LEIDEN and cardiopulmonary bypass: investigation of haemostatic parameters and the effect of aprotinin using an ex vivo model

      PERFUSION-UK
    37. Rubinstein, R; Novitzky, N
      Thrombo-embolic disease - Prevalence of factor V Leiden in the Western Cape

      SOUTH AFRICAN MEDICAL JOURNAL
    38. Schleinitz, N; Veit, V; Chouquet, D; Seux, V; Arnoux, D; Mokart, D; Lelong, B; Alessi, MC; Kaplanski, G; Harle, JR
      Acquired factor V inhibitor: aetiology, bleeding risk and treatment with regard to three cases.

      REVUE DE MEDECINE INTERNE
    39. Gill, RQ; Sterling, RK
      Acute liver failure

      JOURNAL OF CLINICAL GASTROENTEROLOGY
    40. Pallotta, R; Dalpra, L; Miozzo, M; Ehresmann, T; Fusilli, P
      A patient defines the interstitial 1q deletion syndrome characterized by antithrombin III deficiency

      AMERICAN JOURNAL OF MEDICAL GENETICS
    41. Psaty, BM; Smith, NL; Lemaitre, RN; Vos, HL; Heckbert, SR; LaCroix, AZ; Rosendaal, FR
      Hormone replacement therapy, prothrombotic mutations, and the risk of incident nonfatal myocardial infarction in postmenopausal women

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    42. Toulon, P; Adda, R; Perez, P
      Sensitivity of the ProC((R)) global assay for protein C pathway abnormalities. Clinical experience in 899 unselected patients with venous thromboembolism

      THROMBOSIS RESEARCH
    43. Hsu, TS; Hsu, LA; Chang, CJ; Sun, CF; Ko, YL; Kuo, CT; Chiang, CW; Lee, YS
      Importance of hyperhomocysteinemia as a risk factor for venous thromboembolism in a Taiwanese population. A case-control study

      THROMBOSIS RESEARCH
    44. Madonna, P; Piemontino, U; De Stefano, V; Albisinni, R; Cerbone, AM; Di Minno, G
      Coexistence of thrombophilic gene polymorphisms among 559 unrelated consecutive patients with a history of thrombosis

      THROMBOSIS RESEARCH
    45. Hankey, GJ; Eikelboom, JW; van Bockxmeer, FM; Lofthouse, E; Staples, N; Baker, RI
      Inherited thrombophilia in ischemic stroke and its pathogenic subtypes

      STROKE
    46. Abramson, N; Abramson, S
      Hypercoagulability: Clinical assessment and treatment

      SOUTHERN MEDICAL JOURNAL
    47. Eldridge, J; Dilley, A; Austin, H; EL-Jamil, M; Wolstein, L; Doris, J; Hooper, WC; Meehan, PL; Evatt, B
      The role of protein C, protein S, and resistance to activated protein C inLegg-Perthes disease

      PEDIATRICS
    48. Catto, AJ
      Genetic aspects of the hemostatic system in cerebrovascular disease

      NEUROLOGY
    49. Undas, A; Williams, EB; Butenas, S; Orfeo, T; Mann, KG
      Homocysteine inhibits inactivation of Factor Va by activated protein C

      JOURNAL OF BIOLOGICAL CHEMISTRY
    50. Curat, CA; Eck, M; Dervillez, X; Vogel, WF
      Mapping of epitopes in discoidin domain receptor 1 critical for collagen binding

      JOURNAL OF BIOLOGICAL CHEMISTRY
    51. Myles, T; Yun, TH; Hall, SW; Leung, LLK
      An extensive interaction interface between thrombin and factor V is required for factor V activation

      JOURNAL OF BIOLOGICAL CHEMISTRY
    52. Zeibdawi, AR; Pryzdial, ELG
      Mechanism of factor Va inactivation by plasmin - Loss of A2 and A3 domainsfrom a Ca2+-dependent complex of fragments bound to phospholipid

      JOURNAL OF BIOLOGICAL CHEMISTRY
    53. Kalafatis, M; Mann, KG
      The role of the membrane in the inactivation of factor Va by plasmin - Amino acid region 307-348 of factor V plays a critical role in factor Va cofactor function

      JOURNAL OF BIOLOGICAL CHEMISTRY
    54. Tripodi, A; Mannucci, PM
      Laboratory investigation of thrombophilia

      CLINICAL CHEMISTRY
    55. Reyes, AA; Ugozzoli, LA; Lowery, JD; Breneman, JW; Hixson, CS; Press, RD; Wallace, RB
      Linked linear amplification: A new method for the amplification of DNA

      CLINICAL CHEMISTRY
    56. Walker, ID; Greaves, M; Preston, FE
      Investigation and management of heritable thrombophilia

      BRITISH JOURNAL OF HAEMATOLOGY
    57. Lensen, R; Bertina, RM; Vandenbroucke, JP; Rosendaal, FR
      High factor VIII levels contribute to the thrombotic risk in families withfactor V Leiden

      BRITISH JOURNAL OF HAEMATOLOGY
    58. Spiegel, PC; Jacquemin, M; Saint-Remy, JMR; Stoddard, BL; Pratt, KP
      Structure of a factor VIIIC2 domain-immunoglobulin G4 kappa Fab complex: identification of an inhibitory antibody epitope on the surface of factor VIII

      BLOOD
    59. Parker, J; Pagliuca, A; Kitiyakara, T; Whitehead, M; Heaton, N; O'Grady, J; Arya, R
      Discrepancy between phenotype and genotype on screening for factor V Leiden after transplantation

      BLOOD
    60. Barrow, RT; Healey, JF; Jacquemin, MG; Saint-Remy, JMR; Lollar, P
      Antigenicity of putative phospholipid membrane-binding residues in factor VIII

      BLOOD
    61. Srivastava, A; Quinn-Allen, MA; Kim, SW; Kane, WH; Lentz, BR
      Soluble phosphatidylserine binds to a single identified site in the C2 domain of human factor V-a

      BIOCHEMISTRY
    62. Federman, DG; Kirsner, RS
      An update on hypercoagulable disorders

      ARCHIVES OF INTERNAL MEDICINE
    63. Ortel, TL; Mercer, MC; Thames, EH; Moore, KD; Lawson, JH
      Immunologic impact and clinical outcomes after surgical exposure to bovinethrombin

      ANNALS OF SURGERY
    64. Middeldorp, S; Meinardi, JR; Koopman, MMW; van Pampus, ECM; Hamulyak, K; van der Meer, J; Prins, MH; Buller, HR
      A prospective study of asymptomatic carriers of the factor V Leiden mutation to determine the incidence of venous thromboembolism

      ANNALS OF INTERNAL MEDICINE
    65. Bauer, KA
      The thrombophilias: Well-defined risk factors with uncertain therapeutic implications

      ANNALS OF INTERNAL MEDICINE
    66. Petrovic, D; Zorc, M; Keber, I; Peterlin, B
      Joint effect of G1691A factor V point mutation and factor VII Arg/Gln(353)gene polymorphism on the risk of premature coronary artery disease

      ANNALES DE GENETIQUE
    67. Lee, R
      Factor V Leiden: A clinical review

      AMERICAN JOURNAL OF THE MEDICAL SCIENCES
    68. Meyer, G; Emmerich, J; Helley, D; Arnaud, E; Nicaud, V; Alhenc-Gelas, M; Aiach, M; Fischer, AM; Sors, H; Fiessinger, JN
      Factors v Leiden and II 20210A in patients with symptomatic pulmonary embolism and deep vein thrombosis

      AMERICAN JOURNAL OF MEDICINE
    69. Celik, S; Ovali, E; Baykan, M; Ucar, F; Erdol, C; Durmus, I; Kaplan, S
      Factor V Leiden and its relation to left ventricular thrombus in acute myocardial infarction

      ACTA CARDIOLOGICA
    70. Parks, SB; Popovich, BW; Press, RD
      Real-time polymerase chain reaction with fluorescent hybridization probes for the detection of prevalent mutations causing common thrombophilic and iron overload phenotypes

      AJCP. American journal of clinical pathology
    71. Riordan, SM; Williams, R
      Use and validation of selection criteria for liver transplantation in acute liver failure

      LIVER TRANSPLANTATION
    72. Huber, S; McMaster, KJ; Voelkerding, KV
      Analytical evaluation of primer engineered multiplex polymerase chain reaction-restriction fragment length polymorphism for detection of factor V Leiden and prothrombin G20210A

      JOURNAL OF MOLECULAR DIAGNOSTICS
    73. Kamphuisen, PW; Rosendaal, FR; Eikenboom, JCJ; Bos, R; Bertina, RM
      Factor V antigen levels and venous thrombosis - Risk profile, interaction with factor V Leiden, and relation with factor VIII antigen levels

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    74. Bank, I; Middeldorp, S; Buller, HR
      Hereditary and acquired thrombophilia

      SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
    75. Pecheniuk, NM; Walsh, TP; Marsh, NA
      DNA technology for the detection of common genetic variants that predispose to thrombophilia

      BLOOD COAGULATION & FIBRINOLYSIS
    76. Aillaud, MF; Morange, P; Juhan, I; Bauters, A; Jude, B; Biron-Andreani, C; Daures, JP; Schved, JF; Pernod, G; Polac, B; Bridey, F; De Prost, D; Borg, JY; Saladin-Theron, C; Le Cam, V; Denninger, MH; Truchaud, F; Trossaert, M; Boinot, C; Sultan, Y; Delahousse, B; Fimbel, B; Gruel, Y; Houbouyan, L; Bihour, C; Vergnes, C; Dutrillaux, F; Lorenzini, JL; Julia, A; Deschamps, A; Favier, R; Freyburger, G; Trzeciak, MC; Berruyer, M; Doumergue, G; Gris, JC; Toulon, P; Montpied, G; Marques-Verdier, A; Lequerrec, A; Guerin, V; Massignon, D
      Comparison of thrombotic risk between 85 homozygotes and 481 heterozygotescarriers of the factor V Leiden mutation: retrospective analysis from the Procare Study

      BLOOD COAGULATION & FIBRINOLYSIS
    77. Siegert, G; Kostka, H; Gehrisch, S; Schwarz, T; Schellong, S; Jaross, W
      Method-dependent influence of certain polymorphisms in the factor VB-domain on the response to activated protein C

      BLOOD COAGULATION & FIBRINOLYSIS
    78. Toulon, P; Halbmeyer, WM; Hafner, G; Schmitt, Y; Randgard, B; Odpadlik, M; Van den Eynden, C; Wagner, C
      Screening for abnormalities of the protein C anticoagulant pathway using the ProC Global assay. Results of a European multicenter evaluation

      BLOOD COAGULATION & FIBRINOLYSIS
    79. Pecheniuk, NM; Marsh, NA; Walsh, TP
      Multiple analysis of three common genetic alterations associated with thrombophilia

      BLOOD COAGULATION & FIBRINOLYSIS
    80. Nicolaes, GAF; Villoutreix, BO; Dahlback, B
      Mutations in a potential phospholipid binding loop in the C2 domain of factor V affecting the assembly of the prothrombinase complex

      BLOOD COAGULATION & FIBRINOLYSIS
    81. Yetkin, E; Erbay, AR; Ayaz, S; Ileri, M; Yanik, A; Yetkin, G; Cehreli, S; Goksel, S
      Predictors of left ventricular thrombus formation in patients with anterior myocardial infarction: role of activated protein C resistance

      CORONARY ARTERY DISEASE
    82. Quehenberger, P; Handler, S; Mannhalter, C; Pabinger-Fasching, I; Speiser, W
      Evaluation of a highly specific functional test for the detection of factor V Leiden

      INTERNATIONAL JOURNAL OF CLINICAL & LABORATORY RESEARCH
    83. Gowda, MS; Zucker, ML; Vacek, JL; Carriger, WL; Van Laeys, DL; Rachel, JM; Strope, BD
      Incidence of factor V Leiden in patients with acute myocardial infarction

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    84. Makris, TK; Krespi, PG; Hatzizacharias, AN; Gialeraki, AE; Anastasiadis, G; Triposkiadis, FK; Mandalaki, T; Kyriakidis, MK
      Resistance to activated protein C and FV Leiden mutation in patients with a history of acute myocardial infarction or primary hypertension

      AMERICAN JOURNAL OF HYPERTENSION
    85. Jeon, HK; Youn, HJ; Yoo, KD; Park, JW; Kim, HY; Rhim, HY; Chae, JS; Kim, JH; Choi, KB; Hong, SJ
      Transthoracic echocardiographic demonstration of massive pulmonary thrombus caused by protein C deficiency

      JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY
    86. Toulon, P; Perez, P
      Screening for risk factors for thrombosis using a new generation of assaysdeveloped to evaluate the functionality of the protein C anticoagulant pathway

      HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
    87. Kajitani, M; Ozdemir, A; Aguinaga, M; Jazieh, AR; Flick, JT; Antakli, T
      Severe hemorrhagic complication due to acquired factor V inhibitor after single exposure to bovine thrombin product

      JOURNAL OF CARDIAC SURGERY
    88. Van de Water, NS; French, JK; Lund, M; Hyde, TA; White, HD; Browett, PJ
      Prevalence of factor V Leiden and prothrombin variant G20210A in patients age < 50 years with no significant stenoses at angiography three to four weeks after myocardial infarction

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    89. Ioannou, HV; Mitsis, M; Eleftheriou, A; Matsagas, M; Nousias, V; Rigopoulos, C; Vartholomatos, G; Kappas, AM
      The prevalence of Factor V Leiden as a risk factor for venous thromboembolism in the population of North-Western Greece

      INTERNATIONAL ANGIOLOGY
    90. Le, W; Yu, JD; Lu, L; Tao, R; You, B; Cai, X; Gao, WJ; Huang, W; He, RM; Chen, Z; Gong, LS
      Arg485Lys polymorphism of factor V increases the risk of coronary artery disease in a Chinese population

      CHINESE MEDICAL JOURNAL
    91. Angchaisuksiri, P; Pingsuthiwong, S; Aryuchai, K; Busabaratana, M; Sura, T; Atichartakarn, V; Sritara, P
      Prevalence of the G1691A mutation in the factor V gene (factor V Leiden) and the G20210A prothrombin gene mutation in the Thai population

      AMERICAN JOURNAL OF HEMATOLOGY
    92. Irani-Hakime, N; Tamim, H; Kreidy, R; Almawi, WY
      The prevalence of factor V R506Q mutation-Leiden among apparently healthy Lebanese

      AMERICAN JOURNAL OF HEMATOLOGY
    93. Hoekema, L; Rosing, J; Tans, G
      An assay to quantify the two plasma isoforms of Factor V

      THROMBOSIS AND HAEMOSTASIS
    94. Doggen, CJM; de Visser, MCH; Vos, HL; Bertina, RM; Cats, VM; Rosendaal, FR
      The HR2 haplotype of factor V is not associated with the risk of myocardial infarction

      THROMBOSIS AND HAEMOSTASIS
    95. Bauer, KA; Humphries, S; Smillie, B; Li, L; Cooper, JA; Barzegar, S; Rosenberg, RD; Miller, GJ
      Prothrombin activation is increased among asymptomatic carriers of the prothrombin G20210A and factor V Arg506Gln mutations

      THROMBOSIS AND HAEMOSTASIS
    96. Mansourati, J; Da Costa, A; Munier, S; Mercier, B; Tardy, B; Ferec, C; Isaaz, K; Blanc, JJ
      Prevalence of factor V Leiden in patients with myocardial infarction and normal coronary angiography

      THROMBOSIS AND HAEMOSTASIS
    97. de Visser, MCH; Guasch, JF; Kamphuisen, PW; Vos, HL; Rosendaal, FR; Bertina, RM
      The HR2 haplotype of factor V: Effects on factor V levels, normalized activated protein C sensitivity ratios and the risk of venous thrombosis

      THROMBOSIS AND HAEMOSTASIS
    98. Castoldi, E; Rosing, J; Girelli, D; Hoekema, L; Lunghi, B; Mingozzi, F; Ferraresi, P; Friso, S; Corrocher, R; Tans, G; Bernardi, F
      Mutations in the R2 FV gene affect the ratio between the two FV isoforms in plasma

      THROMBOSIS AND HAEMOSTASIS
    99. Voetsch, B; Damasceno, BP; Camargo, ECS; Massaro, A; Bacheschi, LA; Scaff, M; Annichino-Bizzacchi, JM; Arruda, VR
      Inherited thrombophilia as a risk factor for the development of ischemic stroke in young adults

      THROMBOSIS AND HAEMOSTASIS
    100. Renner, W; Koppel, H; Brodmann, M; Pabst, E; Schallmoser, K; Toplak, H; Wascher, TC; Pilger, E
      Factor II G20210A and factor V G1691A gene mutations and peripheral arterial occlusive disease

      THROMBOSIS AND HAEMOSTASIS


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 05/06/20 alle ore 12:44:20